繁 简 About Us Company Profile Corporate Structure Milestones Core Business R&D and Production Base Zhuhai R&D and Production Base Kunming R&D and Production Base Global Sales Network Chinese Medicine Development Chinese Medicine R&D Chinese Medicinal Materials Decoction Slices Biomedical Technology and Products Tianda Products Pipeline Quality Healthcare Services Investor Relations Corporate Information Corporate Governance Announcements & Circulars Financial Statements Shares and Details Investor Calendar Investor Enquiries Email Alerts Notices (Replacement of Lost Share Certificates) Dissemination of Corporate Communications Sustainability Our Sustainable Development ESG Report Careers Wort At Tianda Recruitment Vacancies Internship Programmes Trainee Programmes Media Centre Press Releases Media Coverage Contact Us 2022 Select Year 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 20.12.2022 Tianda Pharma Accelerates Production Capacity Expansion to Fully Support National Epidemic Prevention Extends Chinese Medicine Telemedicine Services across the Nation 25.11.2022 Tianda pharma announces 2022/23 interim results | Steps up efforts in three business segments, Achieves leapfrog development 15.09.2022 TDMall co-organizes event to promote the culture of Chinese medicine 12.07.2022 TDMall became the first Chinese medicine clinic to receive both ISO 9001 and Qualicert International Service Certification 29.06.2022 Tianda Pharmaceuticals Annual Results 2022 ︳Business attained high-quality development 10.05.2022 New R&D and Production Base Put into Production, Tianda Pharmaceuticals sets sail on a new journey 01.04.2022 Together we fight the virus with free consultation and medicine 28.03.2022 TDMall to provide Chinese medicine services for mitigating long COVID 03.03.2022 TDMall offers complimentary online Chinese medical consultation and anti-epidemic care packs to Hong Kong people 12.01.2022 Tianda Pharmaceuticals won the “Best Mid and Small Caps Company” award for two consecutive years